Susana Martins
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Susana Martins has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Nuno Cortez-Dias
University Hospital Santa Maria, Department of Cardiology, Lisbon Academic Medical Centre, CCUL, Lisbon University, Lisbon, Portugal; Programme for Advanced Medical Education, Fundação Calouste Gulbenkian, Ministry of Health and Foundation for Science and Technology, Lisbon, Portugal
9 shared publications António Nunes Diogo
7 shared publicationsAdriana Belo
Centro Nacional de Colecção de Dados em Cardiologia, Sociedade Portuguesa de Cardiologia, Lisboa, Portugal
6 shared publications- Manuela Fiuza
Cardio-Oncology Unit, Serviço de Cardiologia, Centro Hospitalar Universitário Lisboa Norte - EPE, Centro Cardiovascular da Universidade de Lisboa, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal
5 shared publications - Ana Gomes Almeida
Department of Cardiology, Unidade Local de Saúde de Santa Maria, (ULSSM), CAML, CCUL@RISE, Faculdade de Medicina, Universidade de Lisboa , Lisboa
4 shared publications - Manuela Fiuza
Serviço de Cardiologia ULSSM, CAML, CCUL@RISE, FMUL, Portugal
3 shared publications
Latest Publications
- Open Access
- 1 December 2013
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 32 (12) , 987-996
Caracterização do perfil lipídico nos utentes dos cuidados de saúde primários em Portugal
- 1 December 2013
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 32 (12) , 987-996
Open AccessCaracterização do perfil lipídico nos utentes dos cuidados de saúde primários em Portugal
- 1 December 2013
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 32 (12) , 1214-1221
An exploratory panel of biomarkers for risk prediction in pulmonary hypertension: Emerging role of CT-proET-1
- 1 December 2013
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 32 (12) , 1214-1221
An exploratory panel of biomarkers for risk prediction in pulmonary hypertension: Emerging role of CT-proET-1
- 1 October 2013
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 31 (10) , 1991-1997
Association of metabolic risk factors with uncontrolled hypertension
To evaluate the influence of metabolic syndrome in the effectiveness of antihypertensive treatment and to compare it using the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) (2001 and 2004), International Diabetes Federation (IDF) and American Heart Association/National Heart, Lung and Blood Institute (AHA-NHLBI) definitions. The VALSIM (Estudo de Prevalência da Síndrome Metabólica) survey was designed as an observational cross-sectional study performed in a primary healthcare setting in Portugal. The first two adult patients scheduled for an appointment on a given day were invited to participate. The treatment effectiveness was evaluated by the occurrence of uncontrolled hypertension (≥140/90 mmHg) in patients taking antihypertensive drugs. Logistic regression analysis was used to determine the association between uncontrolled hypertension and metabolic risk factors, with adjustments for age, sex, and pattern of antihypertensive treatment. Among the 16,856 individuals evaluated, 8925-treated hypertensive patients were identified. Only 35.8% of them had controlled hypertension. The risk of poor blood pressure control increased with age, waist circumference, serum levels of triglycerides and HDL-cholesterol. Among treatable risk factors, metabolic syndrome as defined by NCEP-ATP III 2001 diagnostic criteria was the strongest independent predictor of uncontrolled hypertension (odds ratio: 1.23; 95% CI: 1.08-1.41; P=0.002). In opposition, the IDF or AHA-NHLBI definitions of metabolic syndrome failed to identify patients at risk of poor blood pressure control. Metabolic syndrome is associated with lower effectiveness of antihypertensive therapy and the NCEP-ATP III 2001 definition of metabolic syndrome is the one that better identifies patients at risk of poor blood pressure control.
- 1 October 2013
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 31 (10) , 1991-1997
Association of metabolic risk factors with uncontrolled hypertension
To evaluate the influence of metabolic syndrome in the effectiveness of antihypertensive treatment and to compare it using the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) (2001 and 2004), International Diabetes Federation (IDF) and American Heart Association/National Heart, Lung and Blood Institute (AHA-NHLBI) definitions. The VALSIM (Estudo de Prevalência da Síndrome Metabólica) survey was designed as an observational cross-sectional study performed in a primary healthcare setting in Portugal. The first two adult patients scheduled for an appointment on a given day were invited to participate. The treatment effectiveness was evaluated by the occurrence of uncontrolled hypertension (≥140/90 mmHg) in patients taking antihypertensive drugs. Logistic regression analysis was used to determine the association between uncontrolled hypertension and metabolic risk factors, with adjustments for age, sex, and pattern of antihypertensive treatment. Among the 16,856 individuals evaluated, 8925-treated hypertensive patients were identified. Only 35.8% of them had controlled hypertension. The risk of poor blood pressure control increased with age, waist circumference, serum levels of triglycerides and HDL-cholesterol. Among treatable risk factors, metabolic syndrome as defined by NCEP-ATP III 2001 diagnostic criteria was the strongest independent predictor of uncontrolled hypertension (odds ratio: 1.23; 95% CI: 1.08-1.41; P=0.002). In opposition, the IDF or AHA-NHLBI definitions of metabolic syndrome failed to identify patients at risk of poor blood pressure control. Metabolic syndrome is associated with lower effectiveness of antihypertensive therapy and the NCEP-ATP III 2001 definition of metabolic syndrome is the one that better identifies patients at risk of poor blood pressure control.
- Open Access
- 1 November 2012
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 31 (11) , 697-699
Angio-TC pulmonar no tromboembolismo pulmonar: para além do diagnóstico
- 1 November 2012
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 31 (11) , 697-699
Open AccessAngio-TC pulmonar no tromboembolismo pulmonar: para além do diagnóstico
- 1 May 2012
- Published by Elsevier in The American Journal of Cardiology
- Vol. 109 (10) , 1431-1438
Cystatin C as Prognostic Biomarker in ST-Segment Elevation Acute Myocardial Infarction
- 1 May 2012
- Published by Elsevier in The American Journal of Cardiology
- Vol. 109 (10) , 1431-1438
Cystatin C as Prognostic Biomarker in ST-Segment Elevation Acute Myocardial Infarction
- 1 April 2012
- Published by Oxford University Press (OUP) in European Heart Journal: Acute Cardiovascular Care
- Vol. 1 (1) , 57-59
Hybrid closure of postinfarction ventricular septal rupture enlargement after transcathether closure with Amplatzer occluder
Ventricular septal rupture (VSR) is nowadays a rare complication of myocardial infarction (MI), but with a mortality rate still very high. Urgent surgical correction is recommended, although in specific cases percutaneous closure of a post-infarct VSR is a therapeutic option or a bridge to surgical correction. We report a case of an 80-year-old woman, with a subacute anterior MI with an antero-septal VSR. Rapid clinical deterioration in a high-surgical-risk patient led us to attempt percutaneous VSR closure at day 8 post MI. A 16-mm Amplatzer post-infarction (PI) muscular VSD closed the defect with intra-cardiac echocardiography guidance, that allowed conscious sedation. Clinical and haemodynamic improvement was immediate. Unfortunately, a small orifice distal to the device persisted, which enlarged to 8 mm over the following days, with a Qp/Qs shunt of 1.9. At day 17 post MI, the VSR was surgically closed by suturing the Amplatzer device to the septum. A residual shunt was evident, but with no progression, being the patient discharged in NYHA class I. Percutaneous closure of a post-MI VSR as a bridge to surgery is a therapeutic option in patients with high surgical risk, allowing haemodynamic stabilization and thus gaining time for a further surgical intervention if needed, improving these patients grim prognosis. Intra-cardiac echocardiography for monitoring the percutaneous procedure instead of a transoesophageal approach, as well as the surgical technique, make this case unique.
- 1 April 2012
- Published by Oxford University Press (OUP) in European Heart Journal: Acute Cardiovascular Care
- Vol. 1 (1) , 57-59
Hybrid closure of postinfarction ventricular septal rupture enlargement after transcathether closure with Amplatzer occluder
Ventricular septal rupture (VSR) is nowadays a rare complication of myocardial infarction (MI), but with a mortality rate still very high. Urgent surgical correction is recommended, although in specific cases percutaneous closure of a post-infarct VSR is a therapeutic option or a bridge to surgical correction. We report a case of an 80-year-old woman, with a subacute anterior MI with an antero-septal VSR. Rapid clinical deterioration in a high-surgical-risk patient led us to attempt percutaneous VSR closure at day 8 post MI. A 16-mm Amplatzer post-infarction (PI) muscular VSD closed the defect with intra-cardiac echocardiography guidance, that allowed conscious sedation. Clinical and haemodynamic improvement was immediate. Unfortunately, a small orifice distal to the device persisted, which enlarged to 8 mm over the following days, with a Qp/Qs shunt of 1.9. At day 17 post MI, the VSR was surgically closed by suturing the Amplatzer device to the septum. A residual shunt was evident, but with no progression, being the patient discharged in NYHA class I. Percutaneous closure of a post-MI VSR as a bridge to surgery is a therapeutic option in patients with high surgical risk, allowing haemodynamic stabilization and thus gaining time for a further surgical intervention if needed, improving these patients grim prognosis. Intra-cardiac echocardiography for monitoring the percutaneous procedure instead of a transoesophageal approach, as well as the surgical technique, make this case unique.
- Open Access
- 1 March 2012
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 31 (3) , 253-254
Ectasia anulo-aórtica em imagem
- 1 March 2012
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 31 (3) , 253-254
Open AccessEctasia anulo-aórtica em imagem
- Open Access
- 1 December 2011
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 30 (12) , 887-889
Potencialidades de novos e velhos biomarcadores na estratificação de risco no tromboembolismo pulmonar
- 1 December 2011
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 30 (12) , 887-889
Open AccessPotencialidades de novos e velhos biomarcadores na estratificação de risco no tromboembolismo pulmonar
- 1 April 2011
- Published by Elsevier in Revista Espanola de Cardiologia
- Vol. 64 (4) , 346
Ecocardiografía tridimensional en la cardiopatía carcinoide
- 1 April 2011
- Published by Elsevier in Revista Espanola de Cardiologia
- Vol. 64 (4) , 346
Ecocardiografía tridimensional en la cardiopatía carcinoide
- Open Access
- 16 February 2011
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 12 (4) , E29
Acute myocardial infarction complication diagnosed by three-dimensional echocardiography
Transthoracic echocardiography is the modality of choice for the bedside diagnosis of acute myocardial infarction mechanical complications. We report the case of a ventricular septal rupture occurring soon after inferior myocardial infarction, revascularized by primary angioplasty. This challenging diagnosis was elucidated by 3D-echocardiography as 2D-imaging was not conclusive. This case demonstrates the importance of 3D-echocardiography in a cardiac intensive care setting. It provided additional information to 2D-echocardiography by identifying and locating post-acute myocardial infarction (AMI) septal rupture with implications for planning surgery.
- 16 February 2011
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 12 (4) , E29
Open AccessAcute myocardial infarction complication diagnosed by three-dimensional echocardiography
Transthoracic echocardiography is the modality of choice for the bedside diagnosis of acute myocardial infarction mechanical complications. We report the case of a ventricular septal rupture occurring soon after inferior myocardial infarction, revascularized by primary angioplasty. This challenging diagnosis was elucidated by 3D-echocardiography as 2D-imaging was not conclusive. This case demonstrates the importance of 3D-echocardiography in a cardiac intensive care setting. It provided additional information to 2D-echocardiography by identifying and locating post-acute myocardial infarction (AMI) septal rupture with implications for planning surgery.